Valuation Yixintang Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 2026-10-16			5-day change	1st Jan Change
12.98 ^CNY	+1.49%		+18.11%	+0.93%

09-16	Yixintang Pharmaceutical Group Co., Ltd. Announces Interim Cash Dividend for 2026 for A Shares, Payable on 24 September 2026	CI
08-27	Yixintang Pharmaceutical Group Co., Ltd. Proposes Interim Cash Dividend for 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,959	18,782	13,803	7,625	7,383	7,452	-	-
Change	-	-18.19%	-26.51%	-44.76%	-3.16%	0.93%	-	-
Enterprise Value (EV) ¹	21,903	16,608	11,574	5,707	6,451	6,213	6,029	5,661
Change	-	-24.17%	-30.31%	-50.69%	13.04%	-3.69%	-2.98%	-6.1%
P/E	24.7x	18.6x	25.2x	67.6x	28.1x	16.5x	13.9x	11.5x
PBR	3.49x	2.53x	1.78x	1.02x	1.03x	1x	0.97x	0.92x
PEG	-	2.14x	-0.6x	-0.9x	0x	0.2x	0.7x	0.6x
Capitalization / Revenue	1.57x	1.08x	0.79x	0.42x	0.43x	0.42x	0.4x	0.37x
EV / Revenue	1.5x	0.95x	0.67x	0.32x	0.37x	0.35x	0.32x	0.28x
EV / EBITDA	16.9x	11x	10.6x	3.13x	9x	3.32x	2.87x	2.35x
EV / EBIT	20.5x	13.4x	11.8x	20.5x	15.3x	8.49x	7.14x	5.67x
EV / FCF	-	-	6.14x	3.89x	4.76x	5.65x	3.99x	3.01x
FCF Yield	-	-	16.3%	25.7%	21%	17.7%	25.1%	33.2%
Dividend per Share ²	0.3	0.4	0.4	0.3	0.2	0.3607	0.4926	0.6117
Rate of return	0.78%	1.27%	1.73%	2.3%	1.56%	2.78%	3.8%	4.71%
EPS ²	1.561	1.697	0.9206	0.1927	0.4571	0.7851	0.9351	1.13
Distribution rate	19.2%	23.6%	43.4%	156%	43.8%	45.9%	52.7%	54.1%
Net sales ¹	14,585	17,432	17,380	18,000	17,336	17,571	18,586	19,934
EBITDA ¹	1,295	1,511	1,087	1,823	716.6	1,874	2,101	2,411
EBIT ¹	1,066	1,243	982.9	278	422.4	731.7	844	997.9
Net income ¹	921.5	1,010	549.4	114.1	263.4	456.2	546.7	663.5
Net Debt ¹	-1,056	-2,174	-2,229	-1,917	-932	-1,239	-1,424	-1,791
Reference price ²	38.51	31.51	23.16	13.02	12.86	12.98	12.98	12.98
Nbr of stocks (in thousands)	596,181	596,071	596,005	585,604	574,128	574,128	-	-
Announcement Date	3/14/22	3/17/23	3/19/24	4/27/25	4/28/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
YIXINTANG PHARMACEUTICAL GROUP CO., LTD.	16.53x	0.35x	3.32x	2.78%	1.11B
JD HEALTH INTERNATIONAL INC.	17.52x	0.73x	10.88x	-.--%	15.67B
RAIA DROGASIL S.A.	23.98x	0.97x	10.48x	1.86%	7.07B
TSURUHA HOLDINGS INC.	20.87x	0.36x	5.58x	2.19%	6.34B
MATSUKIYOCOCOKARA & CO.	16.56x	0.73x	7.65x	2.26%	6.34B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	20.77x	0.77x	13.38x	1.05%	6.19B
YIFENG PHARMACY CHAIN CO., LTD.	16.13x	1x	7.04x	2.62%	4.54B
CLICKS GROUP LIMITED	16.59x	1.01x	7.54x	3.9%	3.41B
COSMOS PHARMACEUTICAL CORPORATION	15.93x	0.46x	7.71x	1.32%	3.24B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	14.28x	0.6x	4.66x	5.06%	3.17B
Average	17.92x	0.70x	7.82x	2.3%	5.71B
Weighted average by Cap.	18.48x	0.73x	8.98x	1.69%